Advantages and limits of remote consultations for HIV pre-exposure prophylaxis health pathway: ePrEP qualitative study

被引:0
作者
Faussat, Cathie [1 ,2 ]
Bonnin, Alicia [3 ]
Hilt, Daniel [4 ,5 ]
Riviere-Da Silva, Fabien [4 ,5 ]
Baissin, Christine [4 ,5 ]
Michels, David [4 ,5 ,6 ]
Gras, Guillaume [2 ]
Leclerc, Celine [7 ]
Aumond, Catherine [4 ,5 ]
Grammatico-Guillon, Leslie [1 ,2 ]
机构
[1] Inserm, Fac Med Tours, U1259, Dept Ophthalmol,Team Res,MAVIVH Morphogenese & Ant, Tours, France
[2] Univ Hosp Ctr CHRU Tours, Prevent & Publ Hlth Dept Reg, Tours, France
[3] Fac Med Tours, EES Educ Eth Hlth Res Team, EA 7505, Tours, France
[4] French Nongovt Org, AIDES Assoc, Orleans, France
[5] French Nongovt Org, AIDES Assoc, Pantin, France
[6] Coalit Plus, Community Res Lab, Pantin, France
[7] Ctr Val Loire Reg Hlth Observ, Orleans, France
来源
JOURNAL OF EPIDEMIOLOGY AND POPULATION HEALTH | 2024年 / 72卷 / 02期
关键词
Community health services; Delivery of health care; HIV; Pre -exposure prophylaxis; Remote consultation; Qualitative research;
D O I
10.1016/j.jeph.2024.202201
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Because of a high rate of HIV diagnosis and restricted medical access in the Centre-Val de Loire region in France , remote consultations (RC) with a community-based approach has been implemented to promote access to healthcare. Our study aimed to determine whether RC could improve access to pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) as part of the healthcare pathway associated with PrEP. Materials and Methods: A qualitative approach involving semi-structured interviews with 17 MSM and 3 physicians from specialized sexual health centres was performed, with a mean duration of interview over one hour. The research focused on the health pathway associated with PrEP, from initial awareness to ongoing prescription and follow-up. Results: Transitioning PrEP consultations to RC is feasible, but concerns about a potential decline in care quality compared to traditional sexual health centres follow-ups were noted. Both MSM and physicians recognized that RC could complement face-to-face approaches, especially in terms of organizational benefits. In rural areas, access to specialists through RC was seen as a partial solution, though it could be hindered by barriers in accessing laboratory testing and pharmacy services, like fear of stigmatization. More generally, distrust of medication and the difficulty of discussing sexuality with a GP were highlighted, which could limit the uptake of PrEP without access to specialists. Conclusions: The initiation and uptake of PrEP among MSM are more effectively influenced by initiatives that provide information, reassurance, and facilitate initial procedures, rather than solely through RC. A strategy combining digital and community-based approaches, along with medical expertise, is recommended to increase PrEP utilization among MSM. (c) 2024 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:7
相关论文
共 40 条
  • [1] Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017)
    Annequin, Margot
    Villes, Virginie
    Delabre, Rosemary M.
    Alain, Tristan
    Morel, Stephane
    Michels, David
    Schmidt, Axel Jeremias
    Velter, Annie
    Castro, Daniela
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 : S47 - S56
  • [2] [Anonymous], 2023, L'Assurance Maladie
  • [3] On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial
    Antoni, Guillemette
    Tremblay, Cecile
    Delaugerre, Constance
    Charreau, Isabelle
    Cua, Eric
    Castro, Daniela Rojas
    Raffi, Francois
    Chas, Julie
    Huleux, Thomas
    Spire, Bruno
    Capitant, Catherine
    Cotte, Laurent
    Meyer, Laurence
    Molina, Jean-Michel
    Meyer, L.
    Capitant, C.
    Charreau, I.
    Netzer, E.
    Leturque, N.
    Binesse, J.
    Foubert, V.
    Saouzanet, M.
    Euphrasie, F.
    Carette, D.
    Guillon, B.
    Saidi, Y.
    Aboulker, J. P.
    Spire, B.
    Suzan, M.
    Cattin, G.
    Demoulin, B.
    Sagaon-Teyssier, L.
    Lorente, N.
    Dore, V.
    Choucair, E.
    Le Mestre, S.
    Mennecier, A.
    Etien, N.
    Simon, M. C.
    Diallo, A.
    Gibowski, S.
    Delfraissy, J. F.
    Thompson, D.
    Sas, J.
    Pankovitch, J.
    Klein, M.
    Anis, A.
    Molina, J-M
    Wainberg, M. A.
    Trottier, B.
    [J]. LANCET HIV, 2020, 7 (02): : E113 - E120
  • [4] Bardin L., 2013, LANALYSE DE CONTENU, DOI DOI 10.3917/PUF.BARD.2013.01
  • [5] Billioti de Gage S, 2019, Suivi de l'utilisation de Truvada ou generiques pour une prophylaxie pre-exposition (PrEP) au VIH a partir des donnees du Systeme National des Donnees de Sante (SNDS)
  • [6] Regulation of medical research in France: Striking the balance between requirements and complexity
    Boyer, Laurent
    Fond, Guillaume
    Gauci, Marc-Olivier
    Boussat, Bastien
    [J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2023, 71 (04):
  • [7] HIV treatment-as-prevention and its effect on incidence of HIV among cisgender gay, bisexual, and other men who have sex with men in Australia: a 10-year longitudinal cohort study
    Callander, Denton
    McManus, Hamish
    Gray, Richard T.
    Grulich, Andrew E.
    Carr, Andrew
    Hoy, Jennifer
    Donovan, Basil
    Fairley, Christopher K.
    Holt, Martin
    Templeton, David J.
    Liaw, Siaw-Teng
    McMahon, James H.
    Asselin, Jason
    Petoumenos, Kathy
    Hellard, Margaret
    Pedrana, Alisa
    Elliott, Julian
    Keen, Phillip
    Costello, Jane
    Keane, Richard
    Kaldor, John
    Stoove, Mark
    Guy, Rebecca
    [J]. LANCET HIV, 2023, 10 (06): : E385 - E393
  • [8] Cazein F, 2019, Decouvertes de seropositiviteVIH et diagnostics de SIDA - FRANCE
  • [9] Colin M., 2020, Acceptabilite du renouvellement du traitement pre-exposition du VIH ou PrEP en Medecine Generale: enque^te aupres des patients et des medecins generalistes de la region
  • [10] Diallo A., 2013, Telemedecine et dossier medical personnel: perceptions et attentes des medecins generalistes, P92